Systematic review and meta-analysis of the current literature on tocilizumab in patients with refractory Takayasu arteritis

Systematic review and meta-analysis of the current literature on tocilizumab in patients with refractory Takayasu arteritis - Front Immunol https://t.co/UO1bNoL9hA

10-30-22: China has 17 of the world's 297 pro-Actemra COVID-19 studies; 8 of the world's 55 pro-Actemra COVID-19 meta-analyses (Chun Chen, Weijun Jiang, Zhenlu Li, Lili Luo, Qiu Wei, Jing Zhang, Jie Zhao, Meng Zhao). Limei Kang is China's 9th, world's 56th

Systematic review and meta-analysis of the current literature on tocilizumab in patients with refractory Takayasu arteritis https://t.co/TEQ32wHe8F https://t.co/zwHIeEQzRV

New Research: Systematic review and meta-analysis of the current literature on tocilizumab in patients with refractory Takayasu arteritis: Objective To present the pooled quantitative evidence of baseline characteristics and clinical… https://t.co/D3pXwFr